§ BIOTECHNOLOGY
USD · BiotechnologyABUS
ARBUTUS BIOPHARMA CORP
USDSector · BiotechnologyBeta · 0.75
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
98 increased/new, 47 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/E | 5.6 | P/B | 12.08 |
| EPS (TTM) | 0.82 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Morgan Stanley | 25.9M | 0.0% | n/a |
| Two Seas Capital LP | 18.6M | 1.2% | +47% |
| Whitefort Capital Management, LP | 14.9M | 19.8% | +12% |
| BlackRock, Inc. | 13.0M | 0.0% | −1% |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.7M | n/a | n/a |
| Rubric Capital Management LP | 6.6M | 0.3% | +321% |
◇ AC INTELLIGENCE
Top institutional owners for ABUS as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER22.4% · 0 holders
OTHER41.5% · 106 holders
DEALER / BANK22.9% · 21 holders
PASSIVE / INDEX11.0% · 9 holders
TACTICAL / MACRO1.0% · 4 holders
QUALITY / COMPOUNDER0.6% · 11 holders
INCOME / DEFENSIVE0.3% · 12 holders
SYSTEMATIC / QUANT0.2% · 4 holders
ACTIVIST0.1% · 1 holder
GROWTH / MOMENTUM0.1% · 1 holder
DEEP VALUE0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for ABUS in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention ABUS yet.